🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the makers of acetaminophen, asserting the corporations hid alleged dangers that the medication presented to children's neurological development.

The court filing follows a month after Former President Trump publicized an unverified association between taking Tylenol - referred to as acetaminophen - throughout gestation and autism spectrum disorder in young ones.

Paxton is filing suit against J&J, which formerly manufactured the medication, the exclusive pain medication approved for expectant mothers, and the current manufacturer, which presently makes it.

In a declaration, he stated they "betrayed America by profiting off of suffering and marketing drugs regardless of the dangers."

The manufacturer says there is lacking scientific proof tying Tylenol to autism.

"These companies misled for generations, knowingly endangering countless individuals to increase profits," the attorney general, from the Republican party, stated.

The company commented that it was "deeply concerned by the spread of false claims on the security of acetaminophen and the possible consequences that could have on the well-being of women and children in America."

On its website, Kenvue also said it had "consistently assessed the applicable studies and there is lacking reliable evidence that indicates a proven link between taking paracetamol and autism spectrum disorder."

Associations acting on behalf of medical professionals and health professionals share this view.

ACOG has said paracetamol - the key substance in Tylenol - is one of the few options for pregnant women to treat discomfort and elevated temperature, which can pose major wellness concerns if ignored.

"In multiple decades of research on the use of paracetamol in gestation, zero credible investigations has definitively established that the use of acetaminophen in any trimester of pregnancy causes neurodevelopmental disorders in offspring," the organization commented.

This legal action references current declarations from the Trump administration in asserting the drug is allegedly unsafe.

Recently, the former president generated worry from public health officials when he advised pregnant women to "fight like hell" not to take Tylenol when sick.

Federal regulators then published an announcement that physicians should consider limiting the consumption of acetaminophen, while also declaring that "a direct connection" between the drug and autism in children has not been established.

The Health Department head Kennedy, who supervises the Food and Drug Administration, had vowed in spring to initiate "comprehensive study program" that would identify the origin of autism spectrum disorder in a limited time.

But authorities cautioned that finding a unique factor of autism - thought by researchers to be the consequence of a complicated interplay of genetic and external influences - would prove challenging.

Autism is a form of lifelong neurodivergence and disability that influences how individuals experience and interact with the world, and is recognized using medical professional evaluations.

In his legal document, Paxton - who supports Trump who is campaigning for US Senate - asserts the manufacturer and J&J "deliberately disregarded and sought to suppress the research" around paracetamol and autism spectrum disorder.

The lawsuit seeks to make the companies "destroy any marketing or advertising" that asserts Tylenol is secure for pregnant women.

The court case mirrors the complaints of a group of parents of minors with autism and attention deficit hyperactivity disorder who sued the producers of Tylenol in 2022.

Judicial authorities dismissed the legal action, stating investigations from the family's specialists was lacking definitive proof.